Quest Diagnostics (LTS:0KSX) Accounts Payable: $0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0KSX Quest Diagnostics Inc LTS:0KSX
80 GF Score
Price $235.05
GF Value $194.55
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Quest Diagnostics Accounts Payable?

Quest Diagnostics LTS:0KSX +0.09% 80 Accounts Payable is $0 Mil as of Jun. 2026. GuruFocus rates LTS:0KSX with a GF Score™ of 80/100 and a GF Value™ of $194.55 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Quest Diagnostics's Accounts Payable for the quarter that ended in Jun. 2026 was $0 Mil.

Quest Diagnostics's quarterly Accounts Payable declined from Dec. 2025 ($307 Mil) to Mar. 2026 ($0 Mil) but then stayed the same from Mar. 2026 ($0 Mil) to Jun. 2026 ($0 Mil).

Quest Diagnostics's annual Accounts Payable declined from Dec. 2023 ($378 Mil) to Dec. 2024 ($287 Mil) but then increased from Dec. 2024 ($287 Mil) to Dec. 2025 ($307 Mil).

Quest Diagnostics Accounts Payable Related Terms

Quest Diagnostics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Quest Diagnostics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Diagnostics Accounts Payable Chart

Quest Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 357.00 324.00 378.00 287.00 307.00

Quest Diagnostics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 307.00 0.00 0.00
LTS:0KSX
80GF Score
Quest Diagnostics Inc LTS:0KSX
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Diagnostics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0 Mil mean?
Quest Diagnostics (LTS:0KSX) has a Accounts Payable of $0 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Quest Diagnostics and its competitors.
Is Quest Diagnostics' Accounts Payable too high?
Quest Diagnostics' current Accounts Payable is $0 Mil. Overall, Quest Diagnostics has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Quest Diagnostics' Accounts Payable compare to LH and MTD?
Quest Diagnostics' Accounts Payable of $0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Diagnostics & Research company?
A good Accounts Payable depends on the Medical Diagnostics & Research industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Quest Diagnostics and its competitors. Quest Diagnostics's current Accounts Payable is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Quest Diagnostics (LTS:0KSX) is currently considered Modestly Overvalued. The stock's GF Value™ is $194.55, compared to a current price of $235.05 — trading 20.8% above its estimated fair value. The current Accounts Payable is $0 Mil. Quest Diagnostics' overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Quest Diagnostics (LTS:0KSX), the current Accounts Payable is $0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Quest Diagnostics (LTS:0KSX) Overvalued in 2026?

Based on GuruFocus' analysis, Quest Diagnostics stock appears to be overvalued. The current stock price of $235.05 is trading 20.8% above its estimated GF Value™ of $194.55. GuruFocus considers Quest Diagnostics to be Modestly Overvalued.

Key valuation signals for LTS:0KSX:

  • Accounts Payable: $0 Mil
  • GF Value™: $194.55 vs. price of $235.05 (20.8% above fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the LTS:0KSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Quest Diagnostics Business Description

Address 500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
80GF Score

Get the complete analysis for LTS:0KSX

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$235.05
Price
$194.55
GF Value